Lisa Parker, APRN
Adult Health · Sebastian, FLNPI 1043838451
Payments from drug & device makers
What this record shows
This record is dominated by other: $3,293 of the $4,267 with a category attached, or 77.2%. Angiodynamics, Inc. accounts for 77.9% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $2,164, more than ten times the $95 reported in 2021.
Across 45 payments — averaging $94.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$3K
- Next Science LLC$298
- Bioventus LLC$130
- Johnson & Johnson$115
- Smith+Nephew$103
- Medtronic$82
- plus $217 from 10 others
What the payments were for
- Food & beverage$97423%
- Other$3,29377%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 5 | $3,323 |
| Next Science LLC | 9 | $298 |
| Bioventus LLC | 5 | $130 |
| Johnson & Johnson | 6 | $115 |
| Smith+Nephew | 5 | $103 |
| Medtronic | 4 | $82 |
| Reprise Biomedical, Inc. | 1 | $41 |
| KCI USA, Inc. | 2 | $29 |
| Bard Peripheral Vascular, Inc. | 1 | $27 |
| Cordis US CORP. | 1 | $24 |
| Solventum Corporation | 1 | $17 |
| Kerecis Limited | 1 | $17 |
| AbbVie | 1 | $16 |
| Acacia Pharma Inc | 1 | $16 |
| Urgo Medical North America, LLC | 1 | $16 |
| Shockwave Medical, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$3,293
- Xperience$123
- BlastX$123
- SurgX$123
How this compares
$4,267 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $18,296 |
| Gentamicin Sulfate | 41 | $1,156 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $385 |
| Doxycycline Hyclate | 24 | $241 |
| ClopidogrelClopidogrel Bisulfate | 24 | $228 |
| Fluconazole | 13 | $135 |
| Ciprofloxacin Hcl | 15 | $134 |
| Methylprednisolone | 13 | $122 |
| Levofloxacin | 18 | $120 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $66 |
| Furosemide | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other adult health in Sebastian
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.